# Precision Medicine With Zibotentan in Microvascular Angina

Study · id `cardio:ct-nct04097314` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04097314](<https://clinicaltrials.gov/study/NCT04097314>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04097314

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.

## Technical summary

Registry record NCT04097314. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-18 (actual); primary completion 2023-06-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 225 participants (enrolled count; ClinicalTrials.gov record NCT04097314, source copy `cardio:ctgov-nct04097314-2023-08-04`, retrieved 2026-11-18)
- Started: 2019-10-18 (actual) (ClinicalTrials.gov record NCT04097314, source copy `cardio:ctgov-nct04097314-2023-08-04`, retrieved 2026-11-18)
- Primary completion: 2023-06-08 (actual) (ClinicalTrials.gov record NCT04097314, source copy `cardio:ctgov-nct04097314-2023-08-04`, retrieved 2026-11-18)
- Completion: 2023-06-08 (actual) (ClinicalTrials.gov record NCT04097314, source copy `cardio:ctgov-nct04097314-2023-08-04`, retrieved 2026-11-18)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04097314, source copy `cardio:ctgov-nct04097314-2023-08-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04097314-2023-08-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Precision Medicine With Zibotentan in Microvascular Angina
- Acronym: PRIZE
- Condition: Microvascular Angina
- Intervention (Drug): Zibotentan
- Intervention (Drug): Placebo oral tablet
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER
- Collaborator: King's College London
- Collaborator class: OTHER
- Collaborator: University of Oxford
- Collaborator class: OTHER
- Collaborator: Oxford University Hospitals NHS Trust
- Collaborator class: OTHER
- Collaborator: University of Cambridge
- Collaborator class: OTHER
- Collaborator: Papworth Hospital NHS Foundation Trust
- Collaborator class: OTHER\_GOV
- Collaborator: Blackpool Teaching Hospitals NHS Foundation Trust
- Collaborator class: OTHER
- Collaborator: Royal Free Hospital NHS Foundation Trust
- Collaborator class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY
- Collaborator: Siemens Healthcare Ltd
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Microvascular and vasospastic angina (`cardio:microvascular-and-vasospastic-angina`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)
- Registry lists this organization as a collaborator: King's College London (`cardio:org-king-s-college-london`)
- Registry lists this organization as a collaborator: University of Oxford (`cardio:org-university-of-oxford`)
- Registry lists this organization as a collaborator: Oxford University Hospitals NHS Trust (`cardio:org-oxford-university-hospitals-nhs-trust`)
- Registry lists this organization as a collaborator: University of Cambridge (`cardio:org-university-of-cambridge`)
- Registry lists this organization as a collaborator: Papworth Hospital NHS Foundation Trust (`cardio:org-papworth-hospital-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: Royal Free Hospital NHS Foundation Trust (`cardio:org-royal-free-hospital-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial (`cardio:pubmed-39217504`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Exercise treadmill testing for efficacy evaluation in randomized, controlled trials (`cardio:pubmed-41687797`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9e47af1d031eafef1a567a221ed43a7b029ac8c2acaa481ed937c9988c5b4257
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
